in Reduction Mammoplasty Specimens: A Study of 516 Cases

breast-reduction surgeries were performed in the United States in the year 2005.1 This procedure ranks fifth among the top 5 reconstructive procedures per-formed in 2005 after, tumor excision (3.9 million), lac-eration repair (344 000), scar revision (181 000), and hand surgery (172 000).2 Breast cancer is the most common cancer in women; in 2006, approximately 212920 new cases of invasive breast cancer and 61980 cases of in situ carcinoma were expected to occur among women in United States, resulting in an esti-mated 40 970 deaths.3,4 The reported incidence of incidental carcinomas in breast-reduction specimens ranges from 0.06 % to 0.8%,5-13 but the frequency of clinically occult intraepithelial and invasive mammary neoplasias is not well known among various age groups